Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The CEOs of Gerresheimer, Stevanato Group, and SCHOTT are committed to ensuring ample supply of pharmaceutical containers for any Covid-19 vaccine and treatment that is developed.
read more
Canopy Biosciences has partnered with OnRamp BioInformatics™ to offer their ROSALIND™ interactive data analysis platform for Canopy's gene expression services.
read more
Alimentiv, formerly Robarts Clinical Trials, announced a major rebranding.
read more
Cobra Biologics has signed an agreement with AstraZeneca to manufacture the adenovirus vector-based COVID-19 vaccine candidate AZD1222.
read more
Legacy Pharmaceutical Packaging has purchased a 215,000-square-foot open-space facility to introduce wide-scale 3PL and distribution services.
read more
Inovalon announced a five-year engagement with Cardinal Health to provide a configuration of Inovalon’s ScriptMed Cloud.
read more
Cascade Chemistry has been selected to produce the active pharmaceutical ingredient (API) for clinical trial supplies of RBT-9.
read more
Catalent announced Catalent Biologics will provide vial filling and packaging capacity to AstraZeneca PLC at Catalent’s manufacturing facility in Anagni, Italy.
read more
Batavia Biosciences and Valneva Sweden have entered into a collaboration agreement to accelerate market-access of a low-cost IPV.
read more
Luminer has streamlined its product inspection capabilities by introducing a dedicated 7,000-square-foot inspection suite at its primary manufacturing facility in Lakewood, NJ.
read more
Longhorn Vaccines & Diagnostics and Pharmco have combined to rapidly accelerate coronavirus testing and detection which are critical to combating the global COVID-19 pandemic.
read more
The EIB and BioNTech SE concluded a €100 million debt financing agreement to support the development of the company’s COVID-19 vaccine program.
read more
ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase® platform to develop the cell line essential to the manufacturing of Phylex's universal SARS coronavirus vaccine candidate.
read more
Jacobs has been selected to provide EPCMCQV to retrofit AstraZeneca’s West Chester, Ohio manufacturing facility to deliver a potential vaccine to fight the COVID-19 virus.
read more
Lonza has introduced an enhanced product line aimed at tackling concerns around bias during blinded clinical trials.
read more